APLM Apollomics: Earnings per share for the trailing year

Apollomics Corp (APLM) - corporate logo

Apollomics, Inc. (APLM) ensures trial safety through streamlined international transportation of biomaterials. The business model relies on fixed R&D costs followed by the collection of royalties from pharma behemoths. The EPS growth rate over the last 12 months YoY reflects the impact of binary risks in the US and Chinese markets, with the indicator reaching 99.40.

Apollomics, Inc. (APLM): Net earnings per share (EPS TTM) from 11/23/2025 to 11/13/2026

APLM (Apollomics Corp): analytical breakdowns and indicator data

- current quotes and average value forecast:
Stock Price Apollomics, Inc.|APLM - Price Target Chart
- company stock capitalization data:
Market Value Apollomics Inc.|APLM - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share Apollomics|APLM - Book Capitalization|Market Capitalization to Book Value Ratio apollomicsinc.com|APLM - Aggregate Company Assets
- company total debt and liquidity indicators:
Aggregate Debt to Equity Apollomics, Inc.|APLM - Long-Term Debt to Equity|Current Liabilities to Capital Apollomics, Inc.|APLM - Company Debts|Debt to Book Capitalization Ratio Apollomics Inc.|APLM - Company Long-Term Debt|Company Short-Term Debt Apollomics|Immediate Liquidity apollomicsinc.com
- net income and valuation ratios data:
APLM - Company Net Income|Future Profit Apollomics, Inc.|APLM - P/E Multiple|Market Cap to Projected Earnings Apollomics, Inc.|APLM - PEG Multiple|Enterprise Value to EBITDA Ratio Apollomics Inc.|APLM - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Apollomics|APLM - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months apollomicsinc.com|APLM - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Apollomics, Inc.
- sales and revenue indicators:
APLM - Company Revenue|Company Revenue Forecast Apollomics, Inc.|APLM - P/S Multiple|Forward Price-to-Revenue Multiple Apollomics Inc.
Initial company analysis:Apollomics - APLM
Brand item of Apollomics Inc.

Parallel development of oncology drugs in the US and China shapes a specific expenditure profile for Apollomics, Inc. (APLM), where capital investment efficiency directly impacts net income. The trailing twelve-month (TTM) earnings per share dynamics measure the rate of return change over 12 months, allowing this 12-month YoY EPS growth chart to assess the business model's resilience to regulatory and currency risks.

Competitor analysis

ONC - Net earnings per share (EPS TTM)|Halozyme (HALO) - Earnings per share for the last twelve months|Revolution Medicines Inc - Earnings per share for the trailing year|AAPG (Ascentage) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months CG Oncology Therapeutics CGON|Net earnings per share (EPS TTM) URGN|Net earnings per share (EPS TTM) bicara.com (BCAX)|Earnings per share for the last twelve months Personalis PSNL|ERAS (Erasca Inc) - Earnings per one share for the last 12 months|DCTH - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Y-mAbs Corp|Aura Biosciences, Inc. (AURA) - Earnings per share for the last twelve months|CADL (Candel Therapeutics, Inc.) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Accuray|Earnings per share for the last twelve months SLS|Earnings per share for the last twelve months Actuate Therapeutics, Inc (ACTU)|CTOR - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months TuHURA Biosciences HURA|TARA - Net earnings per share for the last 12 months|Fate Therapeutics - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Aadi Bioscience Inc WHWK|TCRX: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Champions Oncology, Inc.|Earnings per share for the last twelve months XBiotech Inc|CEL-SCI Corp (CVM) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months OSTX (OS Therapies)|RADX (Radiopharm Theranostics Ltd) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ARTV (Artiva Biotherapeutics)|Net earnings per share for the last four quarters Adlai Nortye Ltd (ANL)|VERU - Earnings per share for the last twelve months|TPST (tempesttx.com) - Earnings per share for the last 12 months|XLO: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Renovaro|Net earnings per share for the last 12 months MURA|Kairos Pharma Inc (KAPA) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) OKUR|Net earnings per share (EPS TTM) w2.cytomed.sg (GDTC)|Earnings per share for the last twelve months Curis CRIS|THAR (Tharimmune Inc) - Earnings per one share for the last 12 months|ADVB - Earnings per share for the last twelve months|GNPX: Earnings per share for the last twelve months|calidibio.com (CLDI) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Sunshine Biopharma Inc.|XBIO (Xenetic Biosciences Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Salarius Pharmaceuticals Inc (SLRX)|Net earnings per share (EPS TTM) PPBT|Net earnings per share (EPS TTM) aoncology.com (AONC)|Earnings per share for the last twelve months BeiGene, Ltd. BGNE|CKPT: Earnings per share for the last 12 months|Elevation Oncology, Inc. - Net earnings per share (EPS TTM)|iCAD, Inc. (ICAD) - Net earnings per share for the last 12 months|IKNA: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Notable Labs Corp (NTBL)|Earnings per share for the last twelve months Viracta Therapeutics Inc.|MOR: Earnings per share for the trailing year|Net earnings per share for the last 12 months NAYA (NAYA Biosciences Inc.)|AAPGV (Ascentage Pharma Group International) - Earnings per share for the trailing year